What Does ‘Society’ Value in New Medicines, and How Can We Know?
-
Chair(s):
Prof. Ken Paterson
Honorary Senior Research Fellow,University of Glasgow, Glasgow, United Kingdom -
Session description:
Ms. Ailsa Brown
Principal Health Economist, Scottish Medicines Consortium, Glasgow, United KingdomProfessor Rachel Baker
Professor of Health Economics, Glasgow Caledonian University, Glasgow, United KingdomDr Tom Caparrotta
Lecturer in Clinical Pharmacology, University of Edinburgh, Edinburgh, United KingdomDr Anna Zecharia
Director of Policy and Public Affairs, British Pharmacological Society, London, United Kingdom
Speakers
-
Ailsa BrownPrincipal Health Economist,Scottish Medicines Consortium, Glasgow, United Kingdom
-
Dr Anna ZechariaDirector of Policy and Public Affairs,British Pharmacological Society, London, United Kingdom
-
Dr Tom CaparrottaLecturer in Clinical Pharmacology,University of Edinburgh, Edinburgh, United Kingdom
-
Professor Rachel BakerProfessor of Health Economics,Glasgow Caledonian University, Glasgow, United Kingdom
Leave A Comment